Selective neuronal vulnerability in human prion diseases -: Fatal familial insomnia differs from other types of prion diseases

被引:57
作者
Guentchev, M [1 ]
Wanschitz, J [1 ]
Voigtländer, T [1 ]
Flicker, H [1 ]
Budka, H [1 ]
机构
[1] Univ Vienna, Inst Neurol, A-1097 Vienna, Austria
关键词
D O I
10.1016/S0002-9440(10)65459-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Human transmissible spongiform encephalopathies (TSEs) or prion diseases are neurodegenerative disorders of infectious, inherited or sporadic origin and include Creutzfeldt-Jakob disease (CJD), Gerstmann-Straussler-Scheinker disease (GSS), kuru and fatal familial insomnia (FFI). Clinicopathologic features of FFI differ markedly from other human TSEs. Previous studies demonstrated selective neuronal vulnerability of parvalbumin positive (PV+) GABAergic inhibitory interneurons in sporadic CJD and experimental TSEs, In this report we show uniform severe loss of PVS neurons also in other TSEs such as GSS, kuru, new variant and familial CJD. In contrast, these neurons are mostly well preserved, or only moderately reduced, in FFI. Only PV+ neurons surrounded by isolectin-B4 positive perineuronal nets were severely affected in TSEs, suggesting a factor residing in this type of extracellular matrix around PV+ neurons as modulator for the selective neuronal vulnerability.
引用
收藏
页码:1453 / 1457
页数:5
相关论文
共 22 条
  • [1] Fatal familial insomnia:: a new Austrian family
    Almer, G
    Hainfellner, JA
    Brücke, T
    Jellinger, K
    Kleinert, R
    Bayer, G
    Windl, O
    Kretzschmar, HA
    Hill, A
    Sidle, K
    Collinge, J
    Budka, H
    [J]. BRAIN, 1999, 122 : 5 - 16
  • [2] PARVALBUMIN-IMMUNOREACTIVE NEURONS IN THE CORTEX IN PICKS DISEASE
    ARAI, H
    NOGUCHI, I
    MAKINO, Y
    KOSAKA, K
    HEIZMANN, CW
    IIZUKA, R
    [J]. JOURNAL OF NEUROLOGY, 1991, 238 (04) : 200 - 202
  • [3] Early destruction of the extracellular matrix around parvalbumin-immunoreactive interneurons in Creutzfeldt-Jakob disease
    Belichenko, PV
    Miklossy, J
    Belser, B
    Budka, H
    Celio, MR
    [J]. NEUROBIOLOGY OF DISEASE, 1999, 6 (04) : 269 - 279
  • [4] Parvalbumin-immunoreactive neurons in the hippocampal formation of Alzheimer's diseased brain
    Brady, DR
    Mufson, EJ
    [J]. NEUROSCIENCE, 1997, 80 (04) : 1113 - 1125
  • [5] Budka H, 1998, BRAIN PATHOL, V8, P553
  • [6] PARVALBUMIN IN MOST GAMMA-AMINOBUTYRIC-ACID CONTAINING NEURONS OF THE RAT CEREBRAL-CORTEX
    CELIO, MR
    [J]. SCIENCE, 1986, 231 (4741) : 995 - 997
  • [7] CELIO MR, 1993, HIPPOCAMPUS, V3, P55
  • [8] Marked decrease of neuropeptide Y Y2 receptor binding sites in the hippocampus in murine prion disease
    Diez, M
    Koistinaho, J
    Dearmond, SJ
    Groth, D
    Prusiner, SB
    Hokfelt, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) : 13267 - 13272
  • [9] PARVALBUMIN-IMMUNOREACTIVE CORTICAL-NEURONS IN CREUTZFELDT-JAKOB-DISEASE
    FERRER, I
    CASAS, R
    RIVERA, R
    [J]. ANNALS OF NEUROLOGY, 1993, 34 (06) : 864 - 866
  • [10] Severe, early and selective loss of a subpopulation of GABAergic inhibitory neurons in experimental transmissible spongiform encephalopathies
    Guentchev, M
    Groschup, MH
    Kordek, R
    Liberski, PP
    Budka, H
    [J]. BRAIN PATHOLOGY, 1998, 8 (04) : 615 - 623